Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexuality and the menopause.

Kevan R Wylie1

  • 1Porterbrook Clinic, Sheffield, UK. k.r.wylie@sheffield.ac.uk

The Journal of the British Menopause Society
|December 21, 2006
PubMed
Summary
This summary is machine-generated.

Postmenopausal women commonly experience sexual dysfunction, including low desire. Treatments like vaginal estrogen, tibolone, or estrogen-androgen therapy may improve sexual function, with androgens potentially beneficial for low testosterone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjusting penis length and the potential impact on female sexual satisfaction.

BJU international·2021
Same author

Undergraduate Training in Human Sexuality-Evaluation of the Impact on Medical Doctors' Practice Ten Years After Graduation.

Sexual medicine·2016
Same author

People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.

The journal of sexual medicine·2014
Same author

An update on female sexual function and dysfunction in old age and its relevance to old age psychiatry.

Aging and disease·2012
Same author

The g-spot article--some of its limitations.

The journal of sexual medicine·2012
Same author

Female sexual dysfunction: reality or disease-mongering?

British journal of hospital medicine (London, England : 2005)·2010
Same journal

Mammographic density: a hormonally responsive risk factor for breast cancer.

The journal of the British Menopause Society·2006
Same journal

Reproductive ageing, sex steroids and depression.

The journal of the British Menopause Society·2006
Same journal

Controversies in the use of adjuvant trastuzumab (Herceptin).

The journal of the British Menopause Society·2006
Same journal

Health benefits of weight reduction in postmenopausal women: a systematic review.

The journal of the British Menopause Society·2006
Same journal

Cognitive function testing: the case for standardization and automation.

The journal of the British Menopause Society·2006
Same journal

Hysterectomy and sexual function.

The journal of the British Menopause Society·2006
See all related articles

Area of Science:

  • Reproductive Endocrinology
  • Women's Health
  • Sexual Medicine

Background:

  • Sexual problems, including dyspareunia and decreased sexual desire, are prevalent in postmenopausal women.
  • Hypoactive sexual desire disorder is a common diagnosis for women experiencing a loss of sexual interest or desire during menopause.

Purpose of the Study:

  • To outline the comprehensive assessment of sexual dysfunction in menopausal women.
  • To review current and potential therapeutic interventions for postmenopausal sexual problems.

Main Methods:

  • Assessment includes detailed medical, gynecological, psychiatric, psychosexual, and relationship history.
  • Utilizes self-report questionnaires, physical examinations, and hormonal evaluations.
  • Explores the efficacy of local vaginal estrogen and systemic therapies like tibolone and combined estrogen-androgen therapy.

Related Experiment Videos

Main Results:

  • Vaginal estrogen may improve local genital response but not necessarily sexual interest.
  • Tibolone and estrogen-androgen therapy have shown reported improvements in sexual function.
  • The optimal patient groups for these treatments remain to be clearly defined.

Conclusions:

  • Comprehensive assessment is crucial for diagnosing and managing sexual dysfunction in menopausal women.
  • While various treatments exist, individualized approaches are necessary, with androgens potentially indicated for specific cases.
  • Further research is needed to identify which postmenopausal women will benefit most from different therapeutic strategies.